Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 9

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 8,001–9,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
8001SLURP1 levelsGCST904706749.53e-03
8002Daytime napGCST0114949.52e-03
8003Salad dressing likingGCST900948229.52e-03
8004NUCB2/TXNDC5 ratioGCST903155789.49e-03
8005CCL11/CCL7 ratioGCST903136739.49e-03
8006FCER1A levelsGCST904691989.48e-03
8007FKBP1B/TGFB1 ratioGCST903148369.46e-03
8008IL12A_IL12B/LAG3 ratioGCST903151479.44e-03
8009HSPB1/QDPR ratioGCST903150899.42e-03
8010CD59/PI3 ratioGCST903138589.40e-03
8011Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental healthUKBB000003389.40e-03
8012Sodium in urine | Urine assaysUKBB000007859.39e-03
8013Cholesteryl esters in very small VLDL (UKB data field 23520)GCST902696179.37e-03
8014HMBS/UBAC1 ratioGCST903150669.37e-03
8015Follicular cysts of skin and subcutaneous tissueFING000005479.36e-03
8016Clinical LDL cholesterol levels (UKB data field 23404)GCST902695019.36e-03
8017CSF2 levelsGCST904688849.34e-03
8018Cholesteryl Esters in VLDLGCST905002059.33e-03
8019EBAG9/TBCB ratioGCST903145679.33e-03
8020Principal component-derived dietary pattern 30GCST901330359.32e-03
8021CKAP4 levelsGCST904687589.31e-03
8022SIGLEC5 levelsGCST904706339.31e-03
8023MMP13 levelsGCST904699179.30e-03
8024Duration to complete alphanumeric path task (baseline)GCST905658399.30e-03
8025Mean platelet volume during second trimester of pregnancyGCST903022309.26e-03
8026Sleeplessness / insomnia | SleepUKBB000007789.24e-03
8027ESM1 levelsGCST904691539.24e-03
8028DTI TBSS L2 Anterior limb of internal capsule LGCST903844939.22e-03
8029GP6/SEMA4D ratioGCST903149719.21e-03
8030T1 FreeSurfer aseg MaskVol-to-eTIVGCST903841929.19e-03
8031Serum 25-Hydroxyvitamin D levelsGCST900006149.15e-03
8032APOA levelsUKBB000000409.14e-03
8033Total lipids in small HDLGCST904994569.12e-03
8034EDAR/TREML2 ratioGCST903145929.10e-03
8035Renal failure (PheCode 585)GCST904761189.05e-03
8036CSNK1G2 levelsGCST902406089.03e-03
8037Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)GCST902696769.03e-03
8038Cholesterol to Total Lipids in Small VLDL percentageGCST904997609.02e-03
8039KIAA2013 levelsGCST904696798.93e-03
8040Other enthesopathiesFING000010458.93e-03
8041AHSG levelsGCST904682638.92e-03
8042Postmenopausal breast cancerGCST904281168.92e-03
8043T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903209008.92e-03
8044CPB1/KIRREL2 ratioGCST903142108.91e-03
8045Other diseases of urinary systemFING000010138.89e-03
8046OsteomyelitisFING000009118.89e-03
8047PADI4 levelsGCST904701438.88e-03
8048IL2RA/NCR1 ratioGCST903151618.88e-03
8049FCRL1/TREML2 ratioGCST903147978.87e-03
8050Omega-6 fatty acid levelsGCST905021008.86e-03
8051Linoleic acid to total fatty acids percentageGCST905023378.85e-03
8052Phospholipids to Total Lipids in Very Large HDL percentageGCST905004748.84e-03
8053CSNK2A1 levelsGCST904688898.81e-03
8054Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418378.81e-03
8055ERBB4/UMOD ratioGCST903146928.81e-03
8056PVALB levelsGCST904703938.80e-03
8057BACH1 levelsGCST904684158.79e-03
8058BLMH levelsGCST904684478.79e-03
8059HLA-DMA levelsGCST902414488.78e-03
8060Panic attacks | Mental distressUKBB000006348.76e-03
8061Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST900601918.74e-03
8062HPCAL1/MPIG6B ratioGCST903150738.73e-03
8063Hearing difficulty and hearing difficulty with background noiseGCST902457768.72e-03
8064Gestational thrombocytopeniaGCST903022348.69e-03
8065FOXO1/MAP4K5 ratioGCST903148728.66e-03
8066Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474ECGU0004748.66e-03
8067Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025938.65e-03
8068Insulin pump user (PheCode 250.3)GCST904756808.65e-03
8069Neutrophil countGCST900187488.64e-03
8070DTI autoptx L3 ilf l tractGCST903852078.63e-03
8071Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary OperationsUKBB000005918.59e-03
8072Tiglylcarnitine (C5:1-DC) levelsGCST901998008.55e-03
8073Left bundle branch block (PheCode 426.32)GCST904759588.54e-03
8074NPDC1/PTGDS ratioGCST903155498.54e-03
8075CD93/CLEC14A ratioGCST903139218.53e-03
80761-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levelsGCST902000468.53e-03
8077Alkenylphosphatidylcholine (P-36:3) levelsGCST900249548.52e-03
8078Docosahexaenoic acid to total fatty acids percentageGCST905022808.50e-03
8079LEG1 levelsGCST904697538.49e-03
8080Bread type - Wholemeal or wholegrain | DietUKBB000001078.47e-03
8081IDO1 levelsGCST904695068.47e-03
8082Glucose levelsGCST900187358.46e-03
8083GALNT2 levelsGCST904692968.45e-03
8084Common executive functionGCST905031158.45e-03
8085Vegetables likingGCST900948628.45e-03
8086Deep venous thrombosisGCST904681228.44e-03
8087red blood cell count (RBC, maximum, inv-norm transformed)GCST904763458.42e-03
8088MGAT2 levelsGCST900895608.41e-03
8089AsthmaGCST900860478.41e-03
8090BACH1/NFATC1 ratioGCST903134448.40e-03
8091CRELD2/NUCB2 ratioGCST903142568.38e-03
8092AXL/IL18BP ratioGCST903134208.38e-03
8093ADGRG1 levelsGCST904682408.38e-03
8094Plasma X-24544 levels in chronic kidney diseaseGCST902667578.36e-03
8095Degree of unsaturationGCST905022248.36e-03
8096CD302/IL12A_IL12B ratioGCST903138068.35e-03
8097Dimethylglycine levelsGCST902004248.34e-03
8098SCLY/SORD ratioGCST903158168.33e-03
8099CASP3/SERPINB9 ratioGCST903136428.33e-03
8100Dried fruit likingGCST900947568.32e-03
8101DVT of lower extremitiesFING000004828.31e-03
8102Takes medication for enlarged prostate (Benign prostatic hyperplasia)?GCST904752628.30e-03
8103CDKN1A/PLA2G4A ratioGCST903139748.27e-03
8104CCL13 levelsGCST904685658.27e-03
8105Principal component-derived dietary pattern 4GCST901330098.26e-03
8106EFNA1 levelsGCST904690808.24e-03
8107Triacylglycerol_56:5_[M+NH4]1+ levelsGCST900605548.24e-03
8108ARHGAP25 levelsGCST902426518.21e-03
8109IDP SWI T2star left pallidumGCST900038698.20e-03
8110Type 2 diabetesGCST0101188.19e-03
8111DTI TBSS L2 Superior fronto-occipital fasciculus RGCST903845188.18e-03
8112IGSF3 levelsGCST904695398.18e-03
8113Edema (PheCode 782.3)GCST904762728.18e-03
8114LGALS3 levelsGCST904697618.17e-03
8115IDP dMRI TBSS L1 Superior longitudinal fasciculus RGCST900041158.15e-03
8116Cholesterol in Medium LDLGCST904987078.13e-03
8117ALB levelsGCST900928078.13e-03
8118PADI2 levelsGCST904701428.13e-03
8119CTBS levelsGCST904689008.12e-03
8120Gallbladder polypGCST900186268.11e-03
8121Dronedarone medicationFING000004748.10e-03
8122Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418398.09e-03
8123DTI TBSS L3 Sagittal stratum RGCST903845548.09e-03
8124Hair colour (natural, before greying): Light brown (UKB data field 1747_3)GCST900418388.08e-03
8125Valine levelsGCST900929958.07e-03
8126HippSubfield rh volume CA3-bodyGCST900027028.06e-03
8127T1 FreeSurfer pial rh lateraloccipital areaGCST903858328.06e-03
8128CHI3L1 levelsGCST904687438.06e-03
8129CDH17 levelsGCST904686698.05e-03
8130MZB1 levelsGCST904699878.05e-03
8131mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754488.03e-03
8132APOB/APOA1 ratioGCST900928108.03e-03
8133Concentration of chylomicrons and extremely large VLDL particlesGCST905010108.03e-03
8134Fluid intelligence score decline (difference score)GCST905658628.02e-03
8135Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST900605578.02e-03
8136Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002668.02e-03
8137Bone marrow fat fraction of lumbar vertebra 1GCST906523868.01e-03
8138CSPG4 levelsGCST904688908.01e-03
8139Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)GCST902696777.99e-03
8140Glutamine levelsGCST904972857.99e-03
8141CD83/TNFRSF4 ratioGCST903139077.99e-03
8142SRC/TBL1X ratioGCST903158847.96e-03
8143Type 2 diabetesGCST904681517.95e-03
8144Restless leg syndromeFING000012557.92e-03
8145T1 FreeSurfer DK rh lateraloccipital volumeGCST903857677.91e-03
8146DCTN1/SCAMP3 ratioGCST903144337.89e-03
8147IZUMO4 levelsGCST904237927.87e-03
8148RTN4R levelsGCST904705087.86e-03
8149CNST levelsGCST904688017.84e-03
8150CD74/TNFRSF21 ratioGCST903138977.79e-03
8151ENO2/SCRN1 ratioGCST903146687.79e-03
8152CD84/SORT1 ratioGCST903139187.78e-03
8153Total lipids in large HDLGCST904978157.76e-03
8154Worrier / anxious feelings | Mental healthUKBB000009217.75e-03
8155Biological Mother: Cancer, SkinGCST904754877.73e-03
8156Age at first sexual intercourseGCST900000467.72e-03
8157Isoleucine levelsGCST900928437.72e-03
8158Ulcerative enterocolitisFING000013917.71e-03
8159Lipoma of skin and subcutaneous tissue (PheCode 214.1)GCST904756197.69e-03
8160EGFLAM levelsGCST904216517.67e-03
8161Prescriptions - orlistat | lipase inhibitor,obesityUKBB000006957.67e-03
8162Prescriptions - lipase inhibitor|obesityUKBB000006887.67e-03
8163Free cholesterol in LDL (UKB data field 23421)GCST902695187.66e-03
8164Cholesteryl Esters in HDLGCST904973687.65e-03
8165Unspecified acute lower respiratory infectionFING000013987.64e-03
8166Total lipids in very large VLDLGCST905006077.63e-03
8167F-vegetarian liking (derived food-liking factor)GCST900948637.58e-03
8168rfMRI amplitudes (ICA100 node 15)GCST900046037.55e-03
8169Alanine transaminase (ALT, mean, inv-norm transformed)GCST904751127.54e-03
8170Phospholipids in very large VLDLGCST905006447.50e-03
8171Phosphatidylinositol-O_36:0_[M-H]1- levelsGCST900604807.48e-03
8172ANXA3/HCLS1 ratioGCST903132827.48e-03
8173FUT8/VEGFC ratioGCST903148967.46e-03
8174MMP12 levelsGCST904699167.45e-03
8175BTN2A1/SPINT2 ratioGCST903135507.43e-03
8176Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005137.43e-03
8177F-low caloric food liking (derived food-liking factor)GCST900947957.43e-03
8178SUGT1 levelsGCST904707807.43e-03
8179Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST902697287.42e-03
8180Androsterone sulfate levelsGCST902006747.40e-03
8181Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467ECGA0004677.38e-03
8182Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618)GCST901329267.38e-03
8183Omega-3 fatty acids to total fatty acids percentageGCST905024627.35e-03
8184Deviated nasal septumFING000004097.35e-03
8185RNASE6 levelsGCST904704797.33e-03
8186Gamma glutamyltransferase levels (UKB data field 30730)GCST904680707.31e-03
8187CSNK2A1 or CSNK2B levelsGCST900889637.30e-03
8188HDL cholesterol levelsGCST904973527.29e-03
8189Phospholipids in IDL (UKB data field 23525)GCST902696227.27e-03
8190GZMH/KLRD1 ratioGCST903150167.26e-03
8191DAG1/PLA2G4A ratioGCST903143807.22e-03
8192ARSA/GUSB ratioGCST903133557.20e-03
8193PDCD6IP levelsGCST906189697.20e-03
8194CD69/SNAP23 ratioGCST903138867.20e-03
8195Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695817.19e-03
8196ITGB1/ITGB2 ratioGCST903152257.19e-03
8197Alanine levelsGCST904970857.18e-03
8198ACE2/GGT1 ratioGCST903131537.18e-03
8199Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007317.18e-03
8200Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T484ECGA0004847.15e-03
8201Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930437.15e-03
8202Total Alkenylphosphatidylcholine levelsGCST900258357.15e-03
8203Concentration of IDL particles (UKB data field 23523)GCST902696207.14e-03
8204Eicosenoylcarnitine (C20:1) levelsGCST902001487.13e-03
8205CFB levelsGCST904687237.11e-03
8206Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025927.09e-03
8207MAP2K1 levelsGCST904698517.09e-03
82081-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000757.09e-03
8209ELOA/MAD1L1 ratioGCST903146407.08e-03
8210X-14626 levelsGCST902438617.08e-03
8211Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021667.06e-03
8212Secondary hypothyroidism (PheCode 244.1)GCST904756497.06e-03
8213LAMP3/PRSS8 ratioGCST903152757.04e-03
8214DKK1 levelsGCST904689977.03e-03
8215CD74/NPDC1 ratioGCST903138957.03e-03
8216CD164/LGMN ratioGCST903137417.03e-03
8217PIK3IP1/TNFRSF1A ratioGCST903156537.02e-03
8218Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903027227.02e-03
8219Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481ECGU0004817.02e-03
8220Fasting glucoseGCST902786287.01e-03
8221SEMA3F levelsGCST904705707.01e-03
82221-(1-enyl-stearoyl)-GPE (p-18:0) levelsGCST901999107.01e-03
8223Thyrotoxicosis with toxic multinodular goitreFING000013627.01e-03
8224PPP1R2/TMSB10 ratioGCST903157217.01e-03
8225CEACAM1/GGT1 ratioGCST903140007.00e-03
8226Operation code - appendicectomy | OperationsUKBB000005496.99e-03
8227BCR/NFATC1 ratioGCST903134966.98e-03
8228Cholesterol to Total Lipids in Medium HDL percentageGCST904985166.98e-03
8229Seen a psychiatrist for nerves, anxiety, tension or depression | Mental healthUKBB000007646.97e-03
8230HSD17B14 levelsGCST904694836.96e-03
8231RNF41 levelsGCST904704856.95e-03
8232T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851106.95e-03
8233Concentration of VLDL particlesGCST905002506.95e-03
8234ARHGEF5 levelsGCST904683606.94e-03
8235Sleep apneaGCST904758246.94e-03
8236CKAP4/LAMP3 ratioGCST903140736.92e-03
8237RAB10 levelsGCST904704036.92e-03
8238IDI2 levelsGCST904695056.92e-03
8239TNFRSF4/TNFRSF8 ratioGCST903159386.91e-03
8240Allergic conjunctivitisFING000000676.87e-03
8241CD300C/NBL1 ratioGCST903137926.86e-03
8242RGS10 levelsGCST904704656.83e-03
8243Hair colour (natural, before greying): Blonde (UKB data field 1747_1)GCST900418366.83e-03
8244PAEP/RSPO1 ratioGCST903155936.82e-03
8245TNFSF12/TNFSF13 ratioGCST903159416.81e-03
8246Educational attainment (confirmatory factor analysis Factor 10)GCST903093446.80e-03
8247HippSubfield rh volume GC-ML-DG-headGCST900027016.78e-03
8248LYPD8 levelsGCST904698296.77e-03
8249EGF levelsGCST904690866.76e-03
8250Mean corpuscular hemoglobin concentrationGCST900187456.75e-03
8251Feeling hurtGCST0069516.73e-03
8252DTI autoptx L2 ifo r tractGCST903851796.73e-03
8253CEP20 levelsGCST904687126.71e-03
8254CD99/PIK3IP1 ratioGCST903139296.71e-03
8255Regional enteritis (PheCode 555.1)GCST904760666.71e-03
8256Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levelsGCST900603456.71e-03
8257Sensorineural hearing lossFING000012916.70e-03
8258NECTIN4 levelsGCST904700216.69e-03
8259T1 FreeSurfer DK rh fusiform volumeGCST903857636.69e-03
8260Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230ECGU0002306.67e-03
8261Concentration of LDL particles (UKB data field 23429)GCST902695266.67e-03
8262FCRL5/ICAM3 ratioGCST903148026.67e-03
8263PCDH17/TEK ratioGCST903156066.66e-03
8264PAMR1/RARRES2 ratioGCST903155956.65e-03
8265Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005696.64e-03
8266BMP7 levelsGCST900881576.64e-03
8267Blood glucose levelsGCST900259866.64e-03
8268FTCD levelsGCST904692746.63e-03
82691-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levelsGCST902000706.63e-03
8270IL16/NADK ratioGCST903151526.63e-03
8271MITD1/WWP2 ratioGCST903154586.61e-03
8272Coriander likingGCST900947446.61e-03
8273Red blood cell (erythrocyte) count | Blood countUKBB000007476.61e-03
8274Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652926.61e-03
8275Memory loss or impairmentGCST904755446.60e-03
8276T1 FIRST volume BrStemGCST903839896.58e-03
8277FCRL5 levelsGCST904692086.57e-03
8278Polyneuropathy in diabetes (PheCode 250.6)GCST904756866.56e-03
8279F-deep fried food liking (derived food-liking factor)GCST900947536.56e-03
8280RRM2B levelsGCST904705006.55e-03
8281APP/EGF ratioGCST903133226.54e-03
8282HyperlipidemiaGCST900909946.52e-03
8283INHBC levelsGCST904696156.51e-03
8284Granulocyte percentage of myeloid white cellsGCST0046086.51e-03
8285Cholesterol in IDLGCST904974956.50e-03
8286Noninfectious gastroenteritis | digestiveUKBB000005266.49e-03
8287Hemoglobin A1c levelsGCST900187386.47e-03
8288Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026976.47e-03
8289Glucose levels (UKB data field 23470)GCST902695676.46e-03
8290EVI5 levelsGCST904691586.46e-03
8291PDGFA/SERPINE1 ratioGCST903156186.45e-03
8292Other arthritis (FG)FING000009646.45e-03
8293X-21364 levelsGCST902005666.44e-03
8294IL12A or IL12B levelsGCST904695486.44e-03
8295FIS1/HSPA1A ratioGCST903148256.43e-03
8296ABHD14B/CRADD ratioGCST903131416.43e-03
8297ICAM5 levelsGCST902415416.41e-03
8298CholecystitisFING000002746.41e-03
8299Concentration of large HDL particlesGCST904978286.40e-03
8300Leisure/social activities - None of the above | Social supportUKBB000003996.38e-03
8301QSOX1 levelsGCST904704026.37e-03
8302Free cholesterol in very large VLDLGCST905005816.37e-03
8303N-acetylphenylalanine levels in chronic kidney diseaseGCST902575376.35e-03
8304DTI TBSS L2 Retrolenticular part of internal capsule RGCST903844966.33e-03
8305DLG4 levelsGCST904690016.33e-03
8306DMP1 levelsGCST904690076.33e-03
8307GFER/VASH1 ratioGCST903149226.32e-03
8308Total cholesterol levels in HDLGCST901326816.31e-03
8309Asthma-related acute respiratory infectionsFING000001176.31e-03
8310CASP8/DDX58 ratioGCST903136516.30e-03
8311HSPB6/SNCG ratioGCST903150906.30e-03
8312HAVCR2 levelsGCST904215156.29e-03
8313ICA1/YTHDF3 ratioGCST903151136.29e-03
8314ADGRE2/B4GALT1 ratioGCST903131746.28e-03
8315CPB1/REG1A ratioGCST903142126.27e-03
8316SNX9 levelsGCST904707036.27e-03
8317Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001926.27e-03
8318CA1/HMBS ratioGCST903135736.26e-03
8319ELOA/POLR2F ratioGCST903146436.26e-03
8320LGALS1/LGALS8 ratioGCST903153146.25e-03
8321PVR levelsGCST904703946.24e-03
8322GRAP2/PPP1R2 ratioGCST903149856.23e-03
8323VNN1 levelsGCST904710436.22e-03
8324Mean bone marrow fat fraction of thoracic vertebrae 8-12GCST906523856.21e-03
8325AIFM1/SIRT2 ratioGCST903132216.20e-03
8326RSPO3 levelsGCST904705046.19e-03
8327CANT1/GSTA1 ratioGCST903136166.18e-03
8328AGRP/CCN1 ratioGCST903132026.18e-03
8329Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329686.18e-03
8330F2R levelsGCST904691686.17e-03
8331CTSF/SMPDL3A ratioGCST903143166.17e-03
8332LATS1 levelsGCST904697406.12e-03
8333Nervonoylcarnitine (C24:1) levelsGCST902001436.11e-03
8334Percentage of M9 (GP18)GCST906686966.11e-03
8335Alanine aminotransferase levelsGCST902786176.10e-03
8336Cholesterol to Total Lipids in Medium VLDL percentageGCST904989266.10e-03
8337Other acute lower respiratory infectionsFING000009216.09e-03
8338PDGFB levelsGCST904701896.08e-03
8339Calculus of kidney and ureter | UrolithiasisUKBB000001166.08e-03
8340Type 2 diabetes with neurological manifestations (PheCode 250.24)GCST904756766.08e-03
8341aparc-a2009s rh area G-precuneusGCST900034006.08e-03
8342CD58/TYRO3 ratioGCST903138566.07e-03
8343FADD/NCK2 ratioGCST903147706.07e-03
8344GRPEL1 levelsGCST904694056.04e-03
8345Nasal polypsGCST904681436.04e-03
8346Omega-3 fatty acid levelsGCST905020626.03e-03
8347Hyperglyceridemia (PheCode 272.12)GCST904757246.02e-03
8348CRADD/DARS1 ratioGCST903142346.01e-03
8349Polyunsaturated fatty acid levelsGCST904992716.00e-03
8350DNA methylation PhenoAge accelerationGCST900142926.00e-03
8351Other specified diseases of sebaceous glands (PheCode 706.8)GCST904762155.99e-03
8352Interpolated Age of participant when operation took place | OperationsUKBB000003705.98e-03
8353SGSH levelsGCST904706155.97e-03
8354PDGFB/USP8 ratioGCST903156335.97e-03
8355Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | MedicationUKBB000004585.96e-03
8356Cholesteryl Esters in Small HDLGCST904993825.96e-03
8357Bone marrow fat fraction of thoracic vertebra 12GCST906523845.95e-03
8358DSG2 levelsGCST904690425.93e-03
8359BANK1/FOXO1 ratioGCST903134565.93e-03
8360Total lipid levels in chylomicrons and extremely large VLDLGCST905010025.92e-03
8361Ascites (non malignant) (PheCode 572)GCST904760905.92e-03
8362CALCB levelsGCST904685295.91e-03
8363CPA4 levelsGCST904688385.90e-03
8364CXCL11 levelsGCST904689245.90e-03
8365FBP1 levelsGCST904691955.90e-03
8366DSG3/FABP9 ratioGCST903145595.90e-03
8367Cholesteryl esters in medium VLDL (UKB data field 23506)GCST902696035.90e-03
8368NECTIN2 levelsGCST904700205.89e-03
8369ICAM4 levelsGCST904695015.88e-03
8370Hearing difficultyGCST902457745.88e-03
8371Conditional arithmetic | Fluid intelligence / reasoningUKBB000001455.86e-03
8372Phenylalanine levelsGCST904992285.86e-03
8373DTI autoptx MD ptr l tractGCST903852395.86e-03
8374FURIN/INHBC ratioGCST903148865.85e-03
8375FOXO1/SNAP23 ratioGCST903148755.84e-03
8376Free cholesterol in medium LDL (UKB data field 23542)GCST902696395.83e-03
8377Principal component-derived dietary pattern 39GCST901330445.83e-03
8378Multi-site chronic pain | Other traitUKBB000004905.83e-03
8379Illnesses of siblings - Diabetes | Family historyUKBB000003505.83e-03
8380GPKOW/PXN ratioGCST903149785.82e-03
8381Cholesterol to Total Lipids in Very Large HDL percentageGCST905003245.81e-03
8382Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST902695825.80e-03
8383CAPG levelsGCST904685375.78e-03
8384Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991945.78e-03
8385NT5C levelsGCST904700925.77e-03
8386CEACAM20 levelsGCST904686935.75e-03
8387Type 2 diabetesGCST0054135.74e-03
8388Phospholipids to Total Lipids in Small HDL percentageGCST904995055.74e-03
8389CD4 levelsGCST904686365.73e-03
8390Degree of unsaturationGCST905001755.72e-03
8391HPCAL1/PMVK ratioGCST903150765.72e-03
8392GAS6 levelsGCST904693055.72e-03
8393Able to confide | Social supportUKBB000000045.71e-03
8394DTI autoptx L2 slf l tractGCST903851875.70e-03
8395Type 2 diabetesGCST900187065.70e-03
8396Recent trouble relaxing | AnxietyUKBB000007455.68e-03
8397Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST902001035.67e-03
8398FABP1/RBP2 ratioGCST903147535.63e-03
83993-Hydroxybutyrate levelsGCST900928115.63e-03
8400EPHB6/LAYN ratioGCST903146815.62e-03
8401Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003595.62e-03
8402DTI TBSS L1 Genu of corpus callosumGCST903844305.61e-03
8403COMP/TGFBI ratioGCST903141925.56e-03
8404REST UKBBICA NODEamps25 0005GCST903854885.55e-03
8405FABP4/FGF21 ratioGCST903147585.54e-03
8406Autorefraction - 3mm asymmetry angle (left) | EyesightUKBB000000605.53e-03
8407S100A4 levelsGCST904705185.52e-03
8408Triglyceride to phosphoglyceride ratioGCST904999965.51e-03
8409AmygNuclei lh volume Whole-amygdalaGCST900026575.51e-03
8410ENO2/ITGB1BP2 ratioGCST903146615.50e-03
8411CD209/CLEC4G ratioGCST903137505.50e-03
8412Pregnenetriol sulfate levelsGCST902002415.50e-03
8413CANT1/NUDT5 ratioGCST903136195.49e-03
8414Body mass index (BMI, minimum, inv-normal transformed)GCST904751595.49e-03
8415CDHR2/SSC4D ratioGCST903139655.48e-03
8416Volume of right medial nucleusGCST904750425.47e-03
8417Phospholipids in medium HDL (UKB data field 23567)GCST902696645.47e-03
8418ANGPT1/DKK1 ratioGCST903132635.46e-03
8419Cough (PheCode 512.8)GCST904760415.45e-03
8420MNX1 levelsGCST900907585.44e-03
8421T1 FreeSurfer BA rh V2 exvivo areaGCST903855575.44e-03
8422SCG2 levelsGCST904705385.43e-03
8423Free cholesterol levels in IDLGCST900928355.42e-03
8424Body fat percentageGCST901037525.42e-03
8425SMPD1/SMPDL3A ratioGCST903158545.41e-03
8426MMP1 levelsGCST904699195.39e-03
8427Crisps likingGCST900947475.38e-03
8428YBX1 levelsGCST900907995.38e-03
8429Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605155.37e-03
8430IPCEF1/SMAD1 ratioGCST903151855.37e-03
8431Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007095.36e-03
8432aparc-DKTatlas rh volume fusiformGCST900028985.33e-03
8433Ingrowing nail (PheCode 703.1)GCST904762085.33e-03
8434DTI TBSS L3 Anterior limb of internal capsule RGCST903845405.32e-03
8435LYN levelsGCST904698265.32e-03
8436Right-hemisphere control network to amygdala white-matter structural connectivityGCST903028415.32e-03
8437AppendectomyFING000001045.32e-03
8438Carnitine levelsGCST902434815.31e-03
8439Concentration of medium HDL particlesGCST900928995.31e-03
8440Childhood body mass indexGCST900024095.29e-03
8441High light scatter reticulocyte percentage | Blood countUKBB000003275.29e-03
8442NECTIN4/SPINK5 ratioGCST903155345.28e-03
8443Reaction timeGCST0034995.27e-03
8444DUSP29 levelsGCST904690525.27e-03
8445PLXNA4/SKAP2 ratioGCST903156855.26e-03
8446PECAM1/SOD2 ratioGCST903156475.25e-03
8447IDP T1 SIENAX white normalised volumeGCST900024325.25e-03
8448Low density lipoprotein cholesterol levelsGCST900024125.24e-03
84494-hydroxyglutamate levelsGCST901998905.24e-03
8450Principal component-derived dietary pattern 23GCST901330285.23e-03
8451Monocyte countGCST900023935.23e-03
8452Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95ECGU0000955.23e-03
8453Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activityUKBB000008705.20e-03
8454Sphingomyelin (d18:1/16:0) levelsGCST900257445.20e-03
8455CRKL/FIS1 ratioGCST903142665.20e-03
8456Low hand grip strength (60 years and older) (FNIH)GCST900075295.19e-03
8457Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007725.19e-03
8458Weekly usage of mobile phone in last 3 months | Electronic device useUKBB000009085.19e-03
8459Cholesterol in large LDL (UKB data field 23533)GCST902696305.17e-03
8460FHIT/PMVK ratioGCST903148225.17e-03
8461GSTA1/PBLD ratioGCST903149945.17e-03
8462WAS levelsGCST904710715.16e-03
8463Fatty acid(20:3)_[M-H]1- levelsGCST900601175.16e-03
8464ENO2 levelsGCST904691105.16e-03
8465CD20 on IgD- CD24- B cellGCST900017535.15e-03
8466Daytime dozing / sleeping (narcolepsy) | SleepUKBB000001645.13e-03
8467SF3B4/SIRT2 ratioGCST903158385.11e-03
8468BCR/GOPC ratioGCST903134915.11e-03
8469monocyte (absolute count, mean, inv-norm transformed)GCST904755025.10e-03
8470PPBP levelsGCST904702895.10e-03
8471Cardiorespiratory fitness slopeGCST900933205.09e-03
8472DCTN1 levelsGCST904689585.09e-03
8473SERPINB13 levelsGCST904233265.09e-03
8474ENPP5 levelsGCST904691165.07e-03
8475Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86ECGU0000865.07e-03
8476Total lipids in very large HDLGCST905004105.04e-03
8477Bone marrow fat fraction of thoracic vertebra 11GCST906523835.03e-03
8478Principal component-derived dietary pattern 45GCST901330505.03e-03
8479ABHD14B levelsGCST904681895.03e-03
8480SERPINE1/USP8 ratioGCST903158355.03e-03
8481ARTN levelsGCST904683725.02e-03
8482ASGR1/GGT5 ratioGCST903133655.01e-03
8483AXIN1/DOK2 ratioGCST903134065.00e-03
8484Cholesteryl esters in large LDL (UKB data field 23534)GCST902696315.00e-03
8485rfMRI connectivity (ICA100 edge 1090)GCST900059435.00e-03
8486Cholesterol_[M+H-H2O]1+ levelsGCST900601334.99e-03
8487HYAL1 levelsGCST904694954.99e-03
8488CDH3 levelsGCST904686744.96e-03
8489Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82ECGU0000824.95e-03
8490TDGF1 levelsGCST904708244.94e-03
8491HGS levelsGCST904694504.94e-03
8492Lung cancerGCST900186554.93e-03
8493Phospholipids in very large VLDL (UKB data field 23490)GCST902695874.93e-03
8494Percentage of M9 (GP18)GCST906684624.93e-03
8495CLEC1B/HEXIM1 ratioGCST903140934.92e-03
8496Interpolated Year when operation took place | OperationsUKBB000003724.92e-03
8497Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)FING000007554.92e-03
8498DTI autoptx L1 ptr r tractGCST903851594.90e-03
8499HypertensionGCST900860914.90e-03
8500Ever suffered mental distress preventing usual activities | Mental distressUKBB000002234.90e-03
8501AmygNuclei rh volume Paralaminar-nucleusGCST900026664.90e-03
8502TRIAP1 levelsGCST904709634.89e-03
8503monocyte (fraction, maximum, inv-norm transformed)GCST904755084.88e-03
8504IDP dMRI ProbtrackX ICVF ml lGCST900043924.88e-03
8505Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493ECGU0004934.88e-03
8506CNTNAP2 levelsGCST904688084.88e-03
8507TGFBR2/TNFRSF1A ratioGCST903159184.88e-03
8508Ulcerative colitisGCST904467954.85e-03
8509Type of accommodation lived in - A house or bungalow | HouseholdUKBB000008694.84e-03
8510TNFRSF13B/TNFSF13B ratioGCST903159334.84e-03
8511CDH5/PEAR1 ratioGCST903139594.84e-03
8512Lawsonibacter sp002161175 abundance in stoolGCST900324594.83e-03
8513CLEC4A levelsGCST904687714.83e-03
8514LECT2 levelsGCST904697514.83e-03
8515Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985564.83e-03
8516CD160/KLRB1 ratioGCST903137314.82e-03
8517NAGPA levelsGCST904699964.81e-03
8518Phospholipids in small HDLGCST904994834.81e-03
8519HGF/PDGFB ratioGCST903150584.81e-03
8520Other disorders of earFING000010234.81e-03
8521CAPN3 levelsGCST904685384.80e-03
8522Pregnancy with abortive outcomeFING000012054.80e-03
8523IDP dMRI TBSS ISOVF Anterior corona radiata LGCST900045004.80e-03
8524GOLM2/ITGA5 ratioGCST903149514.80e-03
8525HBEGF/PDGFB ratioGCST903150344.77e-03
8526EGFL7 levelsGCST904690834.76e-03
8527White blood cell countGCST900023744.76e-03
8528Mean platelet volume during the postpartum periodGCST903022334.76e-03
8529Bipolar disorderGCST0037244.75e-03
8530Bundle branch block (PheCode 426.3)GCST904759564.73e-03
8531Use of disulfiram, acamprosate or naltrexoneFING000014104.72e-03
8532DCTPP1 levelsGCST904689614.71e-03
8533Takes medication for prostate cancer?GCST904751874.70e-03
8534BACH1/EIF4G1 ratioGCST903134384.69e-03
8535Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB000005014.68e-03
8536Free cholesterol in very large VLDL (UKB data field 23493)GCST902695904.67e-03
8537HVEM on Terminally Differentiated CD4+ T cellGCST900018794.67e-03
8538Other non-epithelial cancer of skin (PheCode 172.2)GCST904755804.67e-03
8539GDI2 levelsGCST900880044.66e-03
8540Monocyte count (UKB data field 30130)GCST904680904.66e-03
8541Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)GCST902697344.66e-03
8542aparc-DKTatlas lh volume caudalanteriorcingulateGCST900028634.66e-03
8543VPS53 levelsGCST904710484.64e-03
8544Alcohol consumptionGCST901330034.64e-03
8545Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST902697374.63e-03
8546MLN levelsGCST904699134.61e-03
8547Phenylalanine levelsGCST900929364.61e-03
8548CXCL13 levelsGCST904689264.60e-03
8549TNFRSF17 levelsGCST904709084.59e-03
8550Cholesterol in Medium HDLGCST904984954.58e-03
8551Linoleic acid levelsGCST904983094.58e-03
8552ABL1/PDLIM7 ratioGCST903131504.57e-03
8553Phospholipids in LDLGCST904984394.56e-03
8554ALB levelsGCST904971014.55e-03
8555Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009924.55e-03
8556APOA1 levelsGCST904683314.55e-03
8557Androstenediol (3beta,17beta) monosulfate (2) levelsGCST901998714.54e-03
8558Free cholesterol in large LDL (UKB data field 23535)GCST902696324.52e-03
8559LCN2/PRTN3 ratioGCST903153074.50e-03
8560SDHB levelsGCST904705614.50e-03
8561Haddock likingGCST900947764.50e-03
8562MME/NT5E ratioGCST903154604.48e-03
8563High light scatter reticulocyte count (UKB data field 30300)GCST904680764.48e-03
8564Mean corpuscular haemoglobin concentration (UKB data field 30060)GCST904680854.47e-03
8565Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING000008434.47e-03
8566Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695324.47e-03
8567Valine levelsGCST901327524.46e-03
8568HDL cholesterol levelsGCST904973404.46e-03
8569CTRB1/KIRREL2 ratioGCST903143064.46e-03
8570Phospholipids to total lipids ratio in large VLDLGCST900928774.45e-03
8571DTI TBSS L3 Cingulum hippocampus LGCST903845614.45e-03
8572Small cell lung carcinomaGCST0047464.45e-03
8573Total cholesterol minus HDL-C levels (UKB data field 23401)GCST902694984.45e-03
85741-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levelsGCST901996494.44e-03
8575Total lipids in very large VLDL (UKB data field 23489)GCST902695864.44e-03
8576Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762284.43e-03
8577Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T492ECGU0004924.43e-03
8578BSG/TNFRSF4 ratioGCST903135364.42e-03
8579IntelligenceGCST0043644.40e-03
8580SPRY2/YTHDF3 ratioGCST903158814.40e-03
8581Bone marrow fat fraction of thoracic vertebra 9GCST906523814.39e-03
8582Acute appendicitis, with complicationsFING000000194.38e-03
8583Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009294.38e-03
8584Educational attainmentGCST0025984.37e-03
8585CD226 levelsGCST904686094.36e-03
8586Phospholipids in IDLGCST904976284.36e-03
8587MigraineFING000008184.36e-03
8588IDUA levelsGCST904695084.35e-03
8589Sphingomyelin_33:1_[M+H]1+ levelsGCST900602294.34e-03
8590Phospholipids in LDL (UKB data field 23413)GCST902695104.34e-03
8591Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762024.34e-03
8592PARP1/TCL1A ratioGCST903156024.33e-03
8593Lung adenocarcinomaGCST0047444.33e-03
85941-linoleoyl-GPI (18:2) levelsGCST901998214.33e-03
8595Cereal bar likingGCST900947284.33e-03
8596Free cholesterol in IDLGCST904975644.33e-03
8597APOB levelsGCST902695364.32e-03
8598Cholesteryl esters in very large VLDL (UKB data field 23492)GCST902695894.32e-03
8599RGMB levelsGCST902426474.31e-03
8600Transport type for commuting to job workplace - Public transport | EmploymentUKBB000008284.30e-03
8601EIF4G1/NFATC1 ratioGCST903146374.30e-03
8602DTI autoptx L2 ifo l tractGCST903851784.30e-03
8603ATP5IF1/DECR1 ratioGCST903133824.29e-03
8604Total lipids in large LDL (UKB data field 23531)GCST902696284.29e-03
8605Number of vehicles in household | HouseholdUKBB000005434.28e-03
8606Saturated fatty acids to total fatty acids percentageGCST905022054.28e-03
8607PLIN3/TYMP ratioGCST903156784.28e-03
8608Childhood asthma (age<16) (more control exclusions)FING000002704.27e-03
8609Illnesses of mother - Diabetes | Family historyUKBB000003474.27e-03
8610KIR2DL2 levelsGCST904696844.27e-03
8611Seronegative rheumatoid arthritisFING000012964.26e-03
8612Plays computer games | Electronic device useUKBB000006494.25e-03
8613Concentration of very large VLDL particlesGCST905006284.22e-03
8614Hair colour (natural, before greying) - Light brown | Sun exposureUKBB000002984.21e-03
8615ADIPOQ levelsGCST904682454.20e-03
8616IFNLR1 levelsGCST904695184.19e-03
8617Reticulocyte count | Blood countUKBB000007524.17e-03
8618BCR/FOXO1 ratioGCST903134904.17e-03
8619Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005934.16e-03
8620Paraproteinemia (PheCode 270.32)GCST904757104.16e-03
8621Medical abortionFING000007964.16e-03
8622Triglycerides in very large VLDL (UKB data field 23494)GCST902695914.15e-03
8623COX5B/FXN ratioGCST903141994.15e-03
8624Nasal polypFING000008584.14e-03
8625TOP1 levelsGCST904709334.13e-03
8626Diseases of oesophagus, stomach and duodenumFING000004284.13e-03
8627TF levelsGCST904708414.11e-03
8628Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010454.11e-03
8629HLA-A levelsGCST904694574.11e-03
8630Phospholipids to Total Lipids in Small LDL percentageGCST904996904.11e-03
8631Aspartate aminotransferase (AST, mean, inv-norm transformed)GCST904751214.11e-03
8632CD300C/LRRC25 ratioGCST903137904.10e-03
8633Retinal thickness (functional principal component 1)GCST904557214.10e-03
8634SMPDL3A levelsGCST904706864.10e-03
8635Cholesterol in Small HDLGCST904993484.10e-03
8636CRTAM/FCRL6 ratioGCST903142744.09e-03
8637Volume of left central nucleusGCST904749584.09e-03
8638CD5 levelsGCST902747734.08e-03
8639Hair colour (natural, before greying) - Blonde | Sun exposureUKBB000002964.08e-03
8640Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3)GCST900439464.08e-03
8641Rhodanobacter abundance in stoolGCST900325364.08e-03
8642Exposure to tobacco smoke at home | SmokingUKBB000002284.07e-03
8643High light scatter reticulocyte percentage of red cellsGCST900023864.06e-03
8644CLTA levelsGCST904687914.06e-03
8645Spread type: Butter/spreadable butter (UKB data field 1428_1)GCST901329534.06e-03
8646LY96/ST6GAL1 ratioGCST903153484.05e-03
8647Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST900601734.05e-03
8648CholelithiasisGCST904681184.05e-03
8649Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB000008374.05e-03
8650Birth asphyxiaFING000002184.04e-03
8651SERPINA6 levelsGCST904705864.04e-03
8652SpermatoceleFING000013194.03e-03
8653Physical activity (Total log acceleration)GCST900614084.03e-03
8654PRND levelsGCST904703334.02e-03
8655Exophthalmic conditionsFING000005264.01e-03
8656Staphylococcus A fleurettii abundance in stoolGCST900325644.01e-03
8657LMNB1 levelsGCST904697814.00e-03
8658CD163/MSR1 ratioGCST903137383.99e-03
8659Cognitive processing accuracyGCST904461693.99e-03
8660AmygNuclei lh volume Lateral-nucleusGCST900026483.99e-03
8661Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687583.97e-03
8662Sphingomyelins levels (UKB data field 23438)GCST902695353.96e-03
8663Phospholipids to total lipids ratio in very large HDLGCST900930133.95e-03
8664Free cholesterol in medium VLDL (UKB data field 23507)GCST902696043.95e-03
8665KIT levelsGCST904696923.94e-03
8666BAG6/WASF1 ratioGCST903134523.94e-03
8667Follicular lymphoma, hilmo (controls excluding all cancers)FING000005483.94e-03
8668IL7R levelsGCST904696053.94e-03
8669FGF19 levelsGCST904692203.93e-03
8670ISLR2 levelsGCST904696293.93e-03
8671VEGFC levelsGCST904710363.92e-03
8672IDP T1 SIENAX white unnormalised volumeGCST900024333.92e-03
8673MSR1 levelsGCST904699503.92e-03
8674IDP T1 FAST ROIs R cerebellum VIIIaGCST900025803.92e-03
8675CLEC14A/PTPRS ratioGCST903140813.90e-03
8676CNDP1 levelsGCST904687963.90e-03
8677IDP dMRI TBSS OD Anterior limb of internal capsule RGCST900044183.90e-03
8678TACC3/TBC1D23 ratioGCST903159003.89e-03
8679FXN levelsGCST904692823.89e-03
8680DNMBP/WWP2 ratioGCST903145223.88e-03
8681Body mass indexGCST900259943.88e-03
8682Monounsaturated fatty acids to total fatty acids percentageGCST905023853.87e-03
8683wg lh intensity-contrast parahippocampalGCST900038073.87e-03
8684Type 2 diabetes, definitions combinedFING000013823.86e-03
8685PEAR1/TREML2 ratioGCST903156453.86e-03
8686F-sauces liking (derived food-liking factor)GCST900948313.85e-03
8687Feeling worryGCST0069503.84e-03
8688Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007643.82e-03
8689PDGFB/TNFSF13 ratioGCST903156323.82e-03
8690Thyroid peroxidase antibody levels in pregnancyGCST904352013.82e-03
8691IDP dMRI TBSS ICVF Posterior limb of internal capsule LGCST900043463.81e-03
8692Sphingomyelin_42:2_[M+OAc]1- levelsGCST900605073.81e-03
8693CSF2RB levelsGCST904688833.79e-03
8694Hashimoto thyroiditisGCST900186353.78e-03
8695CA2/NSFL1C ratioGCST903135803.77e-03
8696Blood cell traits latent factor 4 (red cell)GCST905592463.77e-03
8697RNASE1 levelsGCST904704763.76e-03
8698AGXT levelsGCST904682583.76e-03
8699Age at first sexual intercourseGCST900000473.75e-03
8700CALCOCO1/PDLIM7 ratioGCST903136073.75e-03
8701Phospholipids to total lipids ratio in very large VLDLGCST900930253.75e-03
8702ATRAID levelsGCST904683993.74e-03
8703APEX1 levelsGCST904683293.74e-03
8704Modified Stumvoll Insulin Sensitivity IndexGCST902675743.71e-03
8705Concentration of very large VLDL particles (UKB data field 23488)GCST902695853.71e-03
8706Diseases of hair and hair follicles (PheCode 704)GCST904762093.70e-03
8707Familial combined hyperlipidemia defined by Mexico criteriaGCST901040073.70e-03
8708CD40 levelsGCST900120653.70e-03
8709Nonspecific chest pain (PheCode 418)GCST904759473.69e-03
8710Bone marrow fat fraction of thoracic vertebra 8GCST906523803.69e-03
8711DRAXIN levelsGCST904690383.69e-03
8712AmygNuclei rh volume Basal-nucleusGCST900026593.69e-03
8713RGS18 levelsGCST902426173.68e-03
8714Cheese intake | DietUKBB000001273.67e-03
8715VSTM2L levelsGCST904710573.67e-03
8716Phospholipids in large LDL (UKB data field 23532)GCST902696293.67e-03
8717Other diseases of liverFING000010043.67e-03
8718aparc-DKTatlas rh area insulaGCST900032963.65e-03
8719SERPINE1/SPARC ratioGCST903158343.65e-03
8720Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006553.64e-03
8721LDL cholesterol levels (UKB data field 23405)GCST902695023.64e-03
8722Triglycerides in VLDLGCST905002953.61e-03
8723Comparative body size at age 10 | Early life factorsUKBB000001423.61e-03
8724Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | MedicationUKBB000004563.61e-03
8725FADD/NFATC1 ratioGCST903147713.60e-03
8726ANXA3/SERPINB1 ratioGCST903132893.60e-03
8727Body mass indexGCST904466453.60e-03
8728AK1/NSFL1C ratioGCST903132243.59e-03
8729Cerebrospinal fluid proline levelsGCST903182513.59e-03
8730Citrate levels (UKB data field 23473)GCST902695703.59e-03
8731CLEC1B/GP1BA ratioGCST903140913.57e-03
8732Hair colour (natural, before greying) - Black | Sun exposureUKBB000002953.56e-03
8733Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST902751363.56e-03
8734CD83/TREM2 ratioGCST903139083.55e-03
8735F11R levelsGCST904691643.55e-03
8736Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55ECGA0000553.55e-03
8737Creatinine levels (UKB data field 23478)GCST902695753.54e-03
8738SULT2A1 levelsGCST904707823.54e-03
8739HAVCR2/TREM2 ratioGCST903150313.54e-03
8740Total lipids in LDL (UKB data field 23425)GCST902695223.53e-03
8741Ever worried more than most people would in similar situation | AnxietyUKBB000002273.53e-03
8742Rheumatoid arthritisGCST0006793.51e-03
8743GLB1/IMPA1 ratioGCST903149323.50e-03
8744SERPINB6/TXNDC5 ratioGCST903158323.50e-03
8745ALCAM/SPINT1 ratioGCST903132423.49e-03
8746Hypertrophic scarFING000006423.49e-03
8747Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80ECGU0000803.48e-03
8748HSBP1 levelsGCST904694813.48e-03
8749CD38/IL12A_IL12B ratioGCST903138083.48e-03
8750Diseases of sebaceous glands (PheCode 706)GCST904762103.48e-03
8751Cholesteryl esters in small VLDL (UKB data field 23513)GCST902696103.47e-03
8752CD58/ERBB3 ratioGCST903138483.46e-03
8753aseg rh volume AmygdalaGCST900026423.46e-03
8754Smoking status (standard GWA)GCST902673023.46e-03
8755Degree of unsaturationGCST905022253.46e-03
8756Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981653.45e-03
8757Mouth/teeth dental problems - Dentures | MouthUKBB000004863.45e-03
8758Cerotoylcarnitine (C26) levelsGCST902001363.45e-03
8759ACY1 levelsGCST904682123.44e-03
8760TMEM25 levelsGCST904708883.43e-03
8761Degree of unsaturationGCST905027533.43e-03
8762Lower back pain or/and sciaticaFING000007313.43e-03
8763FSTL3 levelsGCST904257653.42e-03
8764CHRDL1 levelsGCST904687503.41e-03
8765IDP dMRI ProbtrackX L1 cgc lGCST900042503.41e-03
8766Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB000003023.40e-03
8767KLK8/WFDC12 ratioGCST903152593.40e-03
8768Haematocrit percentage (UKB data field 30030)GCST904680733.39e-03
8769Psoriasis (vulgaris), strict definitionFING000012233.39e-03
8770Phospholipids to Total Lipids in Large VLDL percentageGCST904982583.39e-03
8771Omega-3 fatty acid levelsGCST905024363.38e-03
8772Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989443.38e-03
8773CXCL11/ITGB1BP2 ratioGCST903143353.38e-03
8774CASP8/PRDX6 ratioGCST903136553.38e-03
8775BLVRB/CA3 ratioGCST903135233.36e-03
8776CPE levelsGCST904688413.36e-03
8777ATOX1/SNAP29 ratioGCST903133743.35e-03
8778Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006923.35e-03
8779Gastric ulcerGCST900186313.35e-03
8780Bone marrow fat fraction of lumbar vertebra 5GCST906523903.35e-03
8781CLEC1B/DKK1 ratioGCST903140883.34e-03
8782Polyunsaturated fatty acids to total fatty acids percentageGCST905021793.34e-03
8783CDKN1A/ENO2 ratioGCST903139693.34e-03
8784T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903209273.34e-03
8785Birth weight known - Yes - pounds and ounces | Early life factorsUKBB000000973.33e-03
8786RGMB/TNFRSF21 ratioGCST903157723.32e-03
8787monocyte (absolute count, maximum, inv-norm transformed)GCST904754993.32e-03
8788LEPR/NTRK2 ratioGCST903153133.32e-03
8789Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755933.32e-03
8790LPO levelsGCST902417303.32e-03
8791T1 FreeSurfer DK lh precuneus volumeGCST903856803.32e-03
8792VSIR levelsGCST904710533.31e-03
8793SERPINB1/TMSB10 ratioGCST903158303.31e-03
8794Free cholesterol in very small VLDL (UKB data field 23521)GCST902696183.31e-03
8795SKAP2 levelsGCST904706463.31e-03
8796Alcohol use disorder, ICD-basedFING000000523.31e-03
8797CEBPB/PXN ratioGCST903140083.30e-03
8798LAT/PDGFA ratioGCST903152853.30e-03
8799IL18BP/THBD ratioGCST903151563.30e-03
8800Leg fat mass (left) | Impedance measuresUKBB000003893.30e-03
8801ADGRE5/NOTCH1 ratioGCST903131813.30e-03
8802CXCL5/SPARC ratioGCST903143553.29e-03
8803Current employment status - Doing unpaid or voluntary work | EmploymentUKBB000001573.28e-03
8804CALCOCO1/TBC1D5 ratioGCST903136103.28e-03
8805Saturated fatty acids to total fatty acids percentageGCST905022073.28e-03
8806Octadecanedioylcarnitine (C18-DC) levelsGCST901999923.28e-03
8807Sphingomyelin_38:2_[M+H]1+ levelsGCST900603023.27e-03
8808Cheesecake likingGCST900947303.27e-03
8809NXF1 levelsGCST902421493.26e-03
8810Enlarged prostate (Benign prostatic hyperplasia)GCST904752613.26e-03
8811T1 FreeSurfer DK rh supramarginal volumeGCST903857873.26e-03
8812Salami likingGCST900948253.25e-03
8813Cognitive function (baseline)GCST905658363.25e-03
8814FABP4/SNCG ratioGCST903147593.25e-03
8815Cholesterol in small LDL (UKB data field 23547)GCST902696443.24e-03
8816HDL cholesterol | Blood biochemistryUKBB000003063.24e-03
8817Ever taken cannabis | Cannabis useUKBB000002243.23e-03
8818Cholesterol in Small LDLGCST904995593.23e-03
8819Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473ECGU0004733.23e-03
8820OXT levelsGCST904701393.23e-03
8821Gamma-CEHC glucuronide levelsGCST901999413.23e-03
8822Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027033.23e-03
8823Cholesteryl esters in LDL (UKB data field 23417)GCST902695143.22e-03
8824IGFBPL1 levelsGCST904695333.22e-03
8825PF4 levelsGCST904702113.21e-03
8826total cholesterol (mean, inv-norm transformed)GCST904764243.21e-03
8827VAT1 levelsGCST904710293.21e-03
8828MSRA/P4HB ratioGCST903154953.20e-03
8829CCN1/DNAJB1 ratioGCST903137093.19e-03
8830Phenylacetate levelsGCST901996303.19e-03
8831FBLN2 levelsGCST904691933.19e-03
8832Free cholesterol in very small VLDLGCST905007773.19e-03
8833DIABLO levelsGCST904689943.19e-03
8834Biological Grandparent (paternal): Coronary Artery / Coronary Heart DiseaseGCST904755483.18e-03
8835Volume of right central nucleusGCST904750243.17e-03
8836KHK levelsGCST904696753.17e-03
8837VASH1 levelsGCST904710263.17e-03
88385alpha-androstan-3beta,17beta-diol disulfate levelsGCST901998353.15e-03
8839TNFRSF11B levelsGCST900120023.15e-03
8840VLDL cholesterol levelsGCST905001893.15e-03
8841C2 levelsGCST904684973.15e-03
8842ICD10 O60: Preterm labor and deliveryGCST904542423.14e-03
8843IL18RAP levelsGCST904695663.14e-03
8844Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)FING000008773.14e-03
8845Concentration of small LDL particles (UKB data field 23544)GCST902696413.13e-03
8846Diabetes diagnosed by doctor | Medical conditionsUKBB000001683.13e-03
8847CD300LG/TNFRSF1A ratioGCST903138033.13e-03
8848Psoas tendinitisFING000012213.13e-03
8849GM3 ganglioside (d18:1/24:0) levelsGCST900253403.12e-03
8850Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56ECGA0000563.12e-03
8851Sleep apneaGCST904752573.11e-03
8852Mean bone marrow fat fraction of lumbar vertebrae 1-5GCST906523913.11e-03
8853Number of sexual partners in opposite-sex sexual behaviorGCST900264823.11e-03
8854AnaemiasFING000000823.11e-03
88553-amino-2-piperidone levelsGCST902001883.10e-03
8856Free cholesterol in small VLDL (UKB data field 23514)GCST902696113.10e-03
8857Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)GCST901329253.10e-03
8858Cholesteryl Esters in HDLGCST904973573.10e-03
8859Volume of right paralaminar nucleusGCST904750513.09e-03
8860AXIN1/NFATC1 ratioGCST903134153.09e-03
8861DAPP1 levelsGCST904689463.09e-03
8862Phospholipid levels in very small VLDLGCST901326593.08e-03
8863Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985803.08e-03
8864Body mass index (BMI, mean, inv-normal transformed)GCST904751563.08e-03
8865STK4 levelsGCST904707673.07e-03
8866Red cell distribution width varianceGCST905657053.06e-03
8867CSF3R levelsGCST904688853.06e-03
8868Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012033.06e-03
8869SNAP29/VEGFC ratioGCST903158623.05e-03
8870Principal component-derived dietary pattern 10GCST901330153.05e-03
8871DTI TBSS L2 Superior fronto-occipital fasciculus LGCST903845193.05e-03
8872T1 FreeSurfer a2009s lh S central thicknessGCST903847863.04e-03
8873Breast cancer (triple negative or BRCA1-positive)GCST0101003.02e-03
8874PLXNA4 levelsGCST904702653.02e-03
8875N-acetylalanine levelsGCST902003033.01e-03
8876IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040943.01e-03
8877Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695783.00e-03
8878EIF4G1/FKBP5 ratioGCST903146333.00e-03
8879Monocyte countGCST0046252.99e-03
8880SPINK5/SPINT1 ratioGCST903158772.99e-03
8881Diseases of middle ear and mastoidFING000004272.98e-03
8882Length of mobile phone use | Electronic device useUKBB000004032.98e-03
8883MPHOSPH8/USP8 ratioGCST903154792.98e-03
8884Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402)GCST902694992.97e-03
8885ARHGAP1 levelsGCST904683522.97e-03
8886ADGRE5/VCAM1 ratioGCST903131842.97e-03
8887GLOD4/HSPA1A ratioGCST903149372.97e-03
8888NECTIN2/VSIR ratioGCST903155332.96e-03
8889CLEC4G/NELL2 ratioGCST903141222.96e-03
8890DAPK2 levelsGCST904689452.96e-03
8891Phospholipids in large VLDLGCST904982432.96e-03
8892CALCOCO1/VPS53 ratioGCST903136122.95e-03
8893TP53BP1 levelsGCST904709362.95e-03
8894HAO1 levelsGCST904694292.95e-03
8895Alcohol drinker status: current or former vs never (UKB data field 20117)GCST901329232.95e-03
8896CTSZ levelsGCST904689182.94e-03
8897Polyunsaturated fatty acid levelsGCST905021422.94e-03
8898TNFRSF19 levelsGCST900889472.94e-03
8899Cholesterol in very large VLDL (UKB data field 23491)GCST902695882.93e-03
89001-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levelsGCST902000602.93e-03
8901SNAP25 levelsGCST904706912.93e-03
8902Cholesterol in IDL (UKB data field 23526)GCST902696232.93e-03
8903Nap during day | SleepUKBB000004922.92e-03
8904BCL2L2 levelsGCST904220772.92e-03
8905Variation in diet | DietUKBB000008922.92e-03
8906Chronic diseases of tonsils and adenoidsFING000002832.92e-03
8907Triglyceride to HDL cholesterol ratioGCST902959492.92e-03
8908T1 CAT volume R RightThalamusGCST903840972.91e-03
8909Free Cholesterol in HDLGCST904973812.91e-03
8910CXCL1 levelsGCST904689302.91e-03
8911CD84/VASH1 ratioGCST903139202.91e-03
8912Leg fat mass (right) | Impedance measuresUKBB000003902.91e-03
8913Eustachian tube disorders (PheCode 381.2)GCST904759042.90e-03
8914Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST902695792.89e-03
8915Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009562.89e-03
8916TriglyceridesGCST900187552.89e-03
8917CPM/PCSK9 ratioGCST903142162.88e-03
8918BA-exvivo lh area BA3bGCST900032102.88e-03
8919DIABLO/GRAP2 ratioGCST903144662.88e-03
8920Malignant neoplasm of liver, primary (PheCode 155.1)GCST904755692.87e-03
8921IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST900041092.87e-03
8922Concentration of IDL particlesGCST904976142.87e-03
8923Hypo-osmolality and hyponatraemiaFING000006482.85e-03
8924Cholesteryl esters in IDL (UKB data field 23527)GCST902696242.84e-03
8925CASP8/PPP3R1 ratioGCST903136542.83e-03
8926Saturated fatty acids to total fatty acids percentageGCST905026962.83e-03
8927Cervicalgia (PheCode 761)GCST904762672.82e-03
8928AXIN1/GOPC ratioGCST903134072.80e-03
8929TNFSF13 levelsGCST904709212.80e-03
8930VTA1 levelsGCST904710582.80e-03
8931Acetate levels (UKB data field 23475)GCST902695722.80e-03
8932CHMP1A levelsGCST904687462.79e-03
8933Mean platelet volume during third trimester of pregnancyGCST903022312.79e-03
8934Total lipids in IDL (UKB data field 23524)GCST902696212.79e-03
8935GOLM2 levelsGCST904693762.79e-03
8936Microvirga abundance in stoolGCST900324792.79e-03
8937Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST903026602.79e-03
8938FYB1/PDGFB ratioGCST903149122.78e-03
8939Concentration of large LDL particlesGCST904980292.78e-03
8940RARRES2/TFPI ratioGCST903157602.78e-03
8941Other headache syndromesFING000010552.78e-03
8942CRTAM/GZMA ratioGCST903142752.77e-03
8943Frequency of drinking alcohol | Alcohol useUKBB000002602.77e-03
8944Phospholipids in large VLDL (UKB data field 23497)GCST902695942.74e-03
8945Immature reticulocyte fraction (UKB data field 30280)GCST904680792.74e-03
8946Monocyte percentage | Blood countUKBB000004802.74e-03
8947MMP8/TGFA ratioGCST903154662.73e-03
8948T1 FreeSurfer a2009s lh G front sup thicknessGCST903847572.73e-03
8949White blood cell countGCST900187582.73e-03
8950CEACAM8/VNN2 ratioGCST903140052.73e-03
8951Bone marrow fat fraction of lumbar vertebra 2GCST906523872.73e-03
8952CTSF/NAAA ratioGCST903143142.72e-03
8953F-highly palatable foods liking (derived food-liking factor)GCST900947852.71e-03
8954LYPD3 levelsGCST904698282.71e-03
8955Enthesopathy (PheCode 726.1)GCST904762392.71e-03
8956SCAMP3/STX4 ratioGCST903158052.70e-03
8957Free Cholesterol to Total Lipids in Small HDL percentageGCST904994362.69e-03
8958MAP4K5/TBCC ratioGCST903153852.69e-03
8959Migraine (PheCode 340)GCST904758372.68e-03
8960Average diameter for VLDL particles (UKB data field 23431)GCST902695282.68e-03
8961CD164/NUDT5 ratioGCST903137422.67e-03
8962Phosphoglycerides levels (UKB data field 23434)GCST902695312.67e-03
8963Omega-3 fatty acids to total fatty acids percentageGCST905024512.66e-03
8964HSPB1 levelsGCST901793172.65e-03
8965Medication use (adrenergics, inhalants)GCST900187792.65e-03
8966SIGLEC8 levelsGCST904706362.65e-03
8967Cholesterol in large VLDL (UKB data field 23498)GCST902695952.65e-03
8968Mild age-related type 2 diabetesGCST900264162.64e-03
8969Other embolism and thrombosisFING000010432.64e-03
8970CIAPIN1/PLA2G4A ratioGCST903140652.63e-03
8971potassium (minimum, inv-norm transformed)GCST904763102.63e-03
8972Other predominantly sexually transmitted diseases, not elsewhere classifiedFING000010892.63e-03
8973Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST902695842.62e-03
8974ENO2/TXNDC5 ratioGCST903146712.61e-03
8975Juvenile arthritis (FINNGEN)FING000007042.61e-03
8976ALDH1A1/RBKS ratioGCST903132472.61e-03
8977B4GALT1/B4GAT1 ratioGCST903134292.61e-03
8978Alcohol drinker status: current vs never (UKB data field 20117)GCST901329242.60e-03
8979Total Lipids in HDLGCST904973932.60e-03
8980Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57ECGA0000572.60e-03
8981IDP T1 FAST ROIs R cerebellum VIIbGCST900025772.59e-03
8982Raynaud's syndromeGCST904481872.59e-03
8983Concentration of large VLDL particles (UKB data field 23495)GCST902695922.59e-03
8984Glucose levelsGCST900928192.58e-03
8985IL12B levelsGCST904695492.58e-03
8986SERPINB1/SERPINB6 ratioGCST903158262.58e-03
8987Ulcerative proctitisFING000013932.57e-03
8988Milky sweets likingGCST900948022.57e-03
8989LILRA2 levelsGCST904697712.57e-03
8990ITGB5/S100A4 ratioGCST903152332.57e-03
8991CD40LG/EREG ratioGCST903138202.57e-03
8992Two-hour glucoseGCST900022272.57e-03
8993TNFSF14 levelsGCST904709222.57e-03
8994Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026952.56e-03
8995Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021532.56e-03
8996Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST902696792.55e-03
8997Fasciitis (PheCode 728.7)GCST904762442.55e-03
8998B4GALT1/SPON2 ratioGCST903134342.54e-03
8999CDC37 levelsGCST904686652.54e-03
9000RELT levelsGCST904704532.54e-03